Target
Bromodomain-containing protein 4 [368-440]
Ligand
BDBM249287
Substrate
n/a
Meas. Tech.
Homogeneous Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay
pH
7.5±n/a
Temperature
298.15±n/a K
IC50
64.8±n/a nM
Comments
extracted
Citation
 Aktoudianakis, EChin, GCorkey, BKDu, JElbel, KJiang, RHKobayashi, TLee, RMartinez, RMetobo, SEMish, MMunoz, MShevick, SSperandio, DYang, HZablocki, J Benzimidazole derivatives as bromodomain inhibitors US Patent  US9458145 Publication Date 10/4/2016 
Target
Name:
Bromodomain-containing protein 4 [368-440]
Synonyms:
BRD4 | BRD4_HUMAN | Bromo domain 2 | Bromodomain-containing protein 4 (BD2) | Bromodomain-containing protein 4 (BRD4) Bromo 2 | Bromodomain-containing protein 4 (BRD4)(BD2) | Bromodomain-containing protein 4 (BRD4)(Bromo 2) | Bromodomain-containing protein 4 Bromo 2 domain(BRD4 BD2) | Bromodomain-containing protein 4 Bromodomain 2 (BRD4-2) | Bromodomain-containing protein 4 Domain 2 | HUNK1
Type:
Protein
Mol. Mass.:
8564.63
Organism:
Homo sapiens (Human)
Description:
BD2 (368-440 aa) of O60885
Residue:
73
Sequence:
KHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVV
  
Inhibitor
Name:
BDBM249287
Synonyms:
US10017501, Compound 1020-77 | US9458145, 1020-77
Type:
Small organic molecule
Emp. Form.:
C18H19N5O
Mol. Mass.:
321.3764
SMILES:
Cc1nc2cc(cc(-c3c(C)n[nH]c3C)c2[nH]1)-c1c(C)noc1C |(-3.83,-5,;-3.06,-3.66,;-3.69,-2.25,;-2.54,-1.22,;-2.54,.32,;-1.21,1.09,;.13,.32,;.13,-1.22,;1.46,-1.99,;2.92,-1.52,;3.69,-.18,;3.83,-2.76,;2.92,-4.01,;1.46,-3.53,;.13,-4.3,;-1.21,-1.99,;-1.53,-3.5,;-1.21,2.63,;.04,3.53,;1.37,2.76,;-.44,5,;-1.98,5,;-2.45,3.53,;-3.79,2.76,)|
Structure:
Search PDB for entries with ligand similarity: